Literature DB >> 19027479

HIV transmission under highly active antiretroviral therapy.

Pietro Vernazza, Bernard Hirschel, Enos Bernasconi, Markus Flepp.   

Abstract

Mesh:

Year:  2008        PMID: 19027479     DOI: 10.1016/S0140-6736(08)61753-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Authors:  Elisa F Long; Douglas K Owens
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

2.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

3.  Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission.

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Christina M Amaral; Denise White; Howard Pope; Connie Swetzes; Lisa Eaton; Rene Macy; Demetria Cain
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

4.  Adherence to antiretroviral therapy and HIV transmission risks: implications for test-and-treat approaches to HIV prevention.

Authors:  Seth C Kalichman; Chauncey Cherry; Christina M Amaral; Connie Swetzes; Lisa Eaton; Rene Macy; Tamar Grebler; Moira O Kalichman
Journal:  AIDS Patient Care STDS       Date:  2010-05       Impact factor: 5.078

5.  Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs.

Authors:  S Finocchario-Kessler; D Catley; J Berkley-Patton; M Gerkovich; K Williams; J Banderas; K Goggin
Journal:  AIDS Patient Care STDS       Date:  2011-01-15       Impact factor: 5.078

6.  Facilitators and Barriers to HIV Status Disclosure Among HIV-positive MSM Age 50 and Older.

Authors:  Perry N Halkitis; Molly J Kingdon; Staci Barton; Jessica Eddy
Journal:  J Gay Lesbian Ment Health       Date:  2015-04-20

7.  The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.

Authors:  Elisa F Long; Margaret L Brandeau; Douglas K Owens
Journal:  Ann Intern Med       Date:  2010-12-21       Impact factor: 25.391

8.  The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Authors:  Jessie L Juusola; Margaret L Brandeau; Douglas K Owens; Eran Bendavid
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

9.  Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention.

Authors:  S C Kalichman; L Eaton; C Cherry
Journal:  HIV Med       Date:  2010-03-01       Impact factor: 3.180

Review 10.  HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention.

Authors:  Rebecca F Baggaley; Richard G White; Marie-Claude Boily
Journal:  Int J Epidemiol       Date:  2010-04-20       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.